Ursodeoxycholic acid - IntraBio
Alternative Names: Ursodiol - IntraBioLatest Information Update: 28 Jul 2021
At a glance
- Originator University of Munich; University of Oxford
- Developer IntraBio
- Class Cholic acids; Gallstone therapies; Hepatoprotectants; Small molecules
- Mechanism of Action Cholesterol inhibitors; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Niemann-Pick disease type C